Collaboration with ANRTSep 10, 2015PRESS RELEASESHit 1101
|
|
|---|---|
|
MedPacto Inc. and ANRT have entered into a collaboration agreement for the development of novel biologics and monoclonal antibodies to develop drugs and diagnosis. The collaboration will focus on the discovery and development of first-in-class therapies and diagnosis tools. Under the terms of the agreement, MedPacto, Inc. will share the outcome from the collaboration with ANRT |
|
| Attachments | |
| Previous | Clinical trial of TEW-7197 starts its first step. |
| Next | Stock issuance |